Artificial Nerve Cells Show Promise

Researchers in Sweden are breaking boundaries in the field of nerve cell communication by creating the first artificial nerve cell capable of communicating with human nerve cells. The research will fuel understanding in the pathophysiology, molecular targets and therapies for the treatment of various nervous system disorders such as Parkinson's disease. The findings have been published in the journal Nature Materials.

Scientists have been stimulating nerve signals in the nervous system by using methods that are based on electrical stimulation. Cochlear implants, for example, are surgically inserted into the cochlea which is located in the inner ear, and electrodes are used in the brain directly. But the researchers from the Karolinska Institute and Linköping University in Sweden found that the current method activates all cell types in the area of the electrode; the result is lacklustre at best.

"Direct electrical interfacing suffers from some inherent problems, such as the inability to discriminate amongst cell types," the study showed. "There is a need for novel devices to specifically interface nerve cells."

In this latest study, the researchers created a new type of 'delivery electrode' by using an electrically conducting plastic. This delivery electrode releases the neurotransmitters that brain cells use to communicate naturally.

"We demonstrate an organic electronic device capable of precisely delivering neurotransmitters in vitro and in vivo. In converting electronic addressing into delivery of neurotransmitters, the device mimics the nerve synapse," the authors wrote.

The team also showed that the delivery electrode can be used to control the hearing function in the brains of guinea pigs.

"The ability to deliver exact doses of neurotransmitters opens completely new possibilities for correcting the signalling systems that are faulty in a number of neurological disease conditions," explained chief researcher Professor Agneta Richter-Dahlfors of the Department of Physiology and Pharmacology at Karolinska Institutet in Sweden.

According to the researchers, "delivery is achieved with minimal physiological disturbances, as electronic signals are translated into ion transport in the absence of fluid flow."

Next on their list is the development of a small unit that can be implanted in the body. For Professor Richter-Dahlfors and her colleague Professor Barbara Canlon, this unit can be programmed to allow the flexible (i.e. as often or as seldom as needed) release of neurotransmitters for each patient.

The innovative technology will benefit patients suffering from various disorders including epilepsy and hearing loss.

"Having demonstrated the ability to translate electronic addressing signals, through neurotransmitter signalling, into brainstem responses, this technology establishes a new paradigm in machine-to-brain interfacing," the authors wrote. "These developments represent a significant step forward in biology-technology interfacing, and promise to pioneer further symbiosis of electronics and living systems."

For further information, please visit:

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...